Accès ouvert
2026
conference-abstract
OpenAlex
You Rui, Jijin Yao, Youping Liu, Mengqi Long et autres
6047 Background: Liposomal mitoxantrone (Lipo-MIT) in combination with programmed death-1 (PD-1) inhibitors exhibits potential synergistic antitumor effects. This study aimed to evaluate the efficacy and safety of this regimen in patients with pretreated recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). Methods: This was a …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yingpeng Peng, Xi Chu, Dasong Zha, Linghan Meng et autres
PURPOSE: Immunotherapy has become the standard first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (R/M NPC). This study aims to explore the impact of discontinuation of immunotherapy within 1 year on survival prognosis in patients with R/M NPC. MATERIALS AND METHODS: We …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Rong Wang, Yingpeng Peng, Ruotong Chen, Rui Liu et autres
PURPOSE: To identify potential roles of RNA modification patterns in immunotherapy and prognosis in head and neck squamous cell carcinoma (HNSCC). METHODS: We performed a multiomics analysis of 26 "writers" from four major adenine RNA modifications in 866 HNSCC samples from 3 …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xuanzi Li, Shuai Yang, Yingpeng Peng, Xueqiang You et autres
PURPOSE: Pineoblastomas (PBs) are rare central nervous system tumors primarily affecting children and adolescents, with limited data on clinical characteristics and survival outcomes. Prognosis prediction models for this disease are lacking. The purpose of this study was to develop deep learning (DL) …
cn, mo
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Qingqing Cai, Jun Ma, Kunyu Yang, Siyang Wang et autres
6031 Background: T cell immunoglobulin and mucin domain molecule 3 (Tim-3) is an inhibitory immune checkpoint receptor that negatively regulates the immune response. This multicenter, single-arm, two-cohort, phase 2 study (NCT05563480) aimed to explore the efficacy and safety of TQB2618, a novel …
cn, hk
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Zhigang Liu, Dong Wang, Guanjun Li, Muhua Yi et autres
6039 Background: Despite standard treatments, mortality rates remain high in locally advanced head and neck squamous cell carcinoma (LA HNSCC). Neoadjuvant immunotherapy combined with chemotherapy has improved response rates, but further enhancement is needed. Recent studies suggest that low-dose radiotherapy (LDR) can …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Fujie Jia, Yingpeng Peng, Xiaobing Li, Shuai Yang et autres
This study investigated the inhibitory effects of matrix metallopeptidase 2 (MMP2)-responsive curcumin-loaded nanoparticles on glioblastoma multiforme (GBM), and elucidated their underlying mechanisms. The methods employed included the Cell Counting Kit-8 viability assay, colony formation assay, flow cytometry for apoptosis analysis, wound healing …
cn
(code pays fourni par la source)
2024
article
OpenAlex
Yingpeng Peng, Shuai Yang, Jianzhong He, Qiaodan Liu et autres
Brain metastasis in nasopharyngeal carcinoma is a rare but poor prognosis clinical problem. This study aims to investigate the clinical characteristics and identify the genomic profiling of nasopharyngeal carcinoma brain metastasis. Patients with a diagnosis of nasopharyngeal carcinoma who visited at the …
cn
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Xuanzi Li, Shuai Yang, Yingpeng Peng, Qiaodan Liu et autres
cn
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Xuanzi Li, Shuai Yang, Qiaodan Liu, Siyang Wang et autres
Abstract Purpose Pineoblastoma (PB) is an extremely uncommon and highly aggressive malignancy that originates from the pineal gland, more frequently occurs in young children. Due to the rare nature, little is known about its prognostic implications and survival outcomes. Existing methods for …
cn
(code pays fourni par la source)
Accès ouvert
2023
conference-abstract
OpenAlex
Zhigang Liu, Yingpeng Peng, Xiaotao Huang, Lizhong Liang et autres
6078 Background: Neoadjuvant immunotherapy and chemotherapy has been explored in phase I/II clinical studies in head and neck squamous cell carcinoma (HNSCC), confirming its safety and efficacy. However, the pathological complete response (pCR) / major pathological response (MPR) rate still needed for …
cn, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Qiaodan Liu, Rong Wang, Zizi Li, Yingpeng Peng et autres
Background: Glioblastoma (GBM) is a highly aggressive intracranial malignant tumor. The role of carboxypeptidase Q (CPQ) in GBM remains unknown. This study was to investigate the prognostic significance of CPQ and its methylation in GBM. Methods: We collected data from The Cancer …
cn
(code pays fourni par la source)